A nomogram model predicting the risk of high-grade cervical squamous intraepithelial lesions: a population-based study

Author:

Zhao Weihong1,Wen Songquan1,Li Qi1,Wang Jingfang1,Zhang Lili1,Wang Yonghong1,Wang Tong2,Hao Min1

Affiliation:

1. Second Hospital of Shanxi Medical University

2. Shanxi Medical University

Abstract

Abstract Purpose: This study aimed to develop a nomogram for the prediction of high-grade cervical squamous intraepithelial lesions (HSILs). Methods: This cross-sectional study included the baseline data of the Shanxi Cervical Intraepithelial Neoplasia (CIN) cohort study, in which 1,249 community-dwelling adults (372 patients with pathologically diagnosed CIN and 877 patients with a normal cervix) from a rural area of Shanxi, China, were recruited. Interviewer-administered questionnaires on sociodemographic characteristics, hygiene habits, marriage and childbearing information, and past medical and family histories of cancer were obtained. Human papillomavirus (HPV) infection types were detected by flow-through hybridization. Logistic regression analysis of independent risk factors for HSILs and a nomogram prediction model were established. Results: Of the 1,249 participants, 460 (36.83%) were infected with high-risk HPV (HR-HPV), and the five most frequent types of HPV were HPV16, HPV52, HPV58, HPV56, and HPV33. After adjusting for demographics and other related variables, HPV16 was associated with an 11.363-fold (95% confidence interval [CI], 6.639–19.449) higher risk of HSILs and HPV58 was associated with a 5.758-fold (95% CI, 2.542–13.045) higher risk of HSILs compared to the uninfected group. HR-HPV infection, younger age at menarche, menopause, and tea drinking were selected as nomogram covariates. The concordance index of the nomogram prediction model was 0.822. Conclusion: The most common highly pathogenic HR-HPV types in the study area are HPV16 and HPV58. An easy-to-use nomogram, with reliable discrimination ability and accuracy, was established to help predict HSILs using the identified significant risk factors. Trial registration: This study was registered by the China Clinical Trials Center (registration number: ChiCTR-ROC-15006479).

Publisher

Research Square Platform LLC

Reference25 articles.

1. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis;Arbyn M;Lancet Glob Health,2018

2. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods;Ferlay J;Int J Cancer,2019

3. An analysis of both high incidence of esophageal and cervical cancer in Yangcheng County, Shanxi Province;Wang XZ;China Cancer,2011

4. An analysis of incidence and mortality of cervical cancer in China, 2003 ~ 2007;Li N;China Cancer,2012

5. Chan CK, Aimagambetova G, Ukybassova T, et al (2019) Human papillomavirus infection and cervical cancer: epidemiology, screening, and vaccination-review of current perspectives. J Oncol 2019:3257939.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3